Literature DB >> 21627763

Revisiting Paulozzi et al.'s "Prescription drug monitoring programs and death rates from drug overdose".

Traci C Green, Nickolas Zaller, Josiah Rich, Sarah Bowman, Peter Friedmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21627763     DOI： 10.1111/j.1526-4637.2011.01136.x

Source DB:  PubMed          Journal:  Pain Med        ISSN： 1526-2375            Impact factor:   3.750


× No keyword cloud information.
  13 in total

1.  Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings.

Authors:  N J Pauly; S Slavova; C Delcher; P R Freeman; J Talbert
Journal:  Drug Alcohol Depend       Date:  2018-01-11       Impact factor: 4.492

2.  Real-time access to prescription drug monitoring databases.

Authors:  Barth Wilsey; Hannah Prasad
Journal:  CMAJ       Date:  2012-09-24       Impact factor: 8.262

3.  Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs.

Authors:  Marcus A Bachhuber; Brendan Saloner; Marc LaRochelle; Jessica S Merlin; Brandon C Maughan; Dan Polsky; Naum Shaparin; Sean M Murphy
Journal:  Pain Med       Date:  2018-10-01       Impact factor: 3.750

4.  Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder.

Authors:  Yih-Ing Hser; Andrew J Saxon; Larissa J Mooney; Karen Miotto; Yuhui Zhu; Caroline K Yoo; Di Liang; David Huang; Douglas S Bell
Journal:  J Addict Med       Date:  2019 Jan/Feb       Impact factor: 3.702

5.  Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011.

Authors:  Corey S Davis; Matthew Pierce; Nabarun Dasgupta
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

6.  Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.

Authors:  Nadia Fairbairn; Phillip O Coffin; Alexander Y Walley
Journal:  Int J Drug Policy       Date:  2017-07-04

Review 7.  A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.

Authors:  Shane R Mueller; Alexander Y Walley; Susan L Calcaterra; Jason M Glanz; Ingrid A Binswanger
Journal:  Subst Abus       Date:  2015-03-16       Impact factor: 3.716

8.  Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis.

Authors:  Tara Gomes; David Juurlink; Zhan Yao; Ximena Camacho; J Michael Paterson; Samantha Singh; Irfan Dhalla; Beth Sproule; Muhammad Mamdani
Journal:  CMAJ Open       Date:  2014-10-01

9.  Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions.

Authors:  Richard A Deyo; Jessica M Irvine; Lisa M Millet; Todd Beran; Nicole O'Kane; Dagan A Wright; Dennis McCarty
Journal:  Health Aff (Millwood)       Date:  2013-02-13       Impact factor: 6.301

10.  Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.

Authors:  Patricia R Freeman; Geoffrey M Curran; Karen L Drummond; Bradley C Martin; Benjamin S Teeter; Katharine Bradley; Nancy Schoenberg; Mark J Edlund
Journal:  Res Social Adm Pharm       Date:  2018-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.